BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Dermatol. Sep 16, 2026; 12(1): 121180
Published online Sep 16, 2026. doi: 10.5314/wjd.121180
Figure 1
Figure 1 Kaplan-Meier curves. A: Showing overall treatment persistence in patients with moderate-to-severe psoriasis treated with secukinumab or guselkumab during the study follow-up period; B: Showing treatment persistence with secukinumab according to prior biologic exposure, comparing biologic-naïve and biologic-experienced patients; C: Showing treatment persistence with guselkumab according to prior biologic exposure, comparing biologic-naïve and biologic-experienced patients.


Write to the Help Desk